Polymorphisms in the Interleukin-1 Receptor Antagonist and Interleukin-6 Genes Affect Risk of Osteolysis in Patients With Total Hip Arthroplasty

被引:59
|
作者
Gordon, Andrew [1 ]
Kiss-Toth, E. [1 ]
Stockley, Ian
Eastell, Richard [1 ]
Wilkinson, J. Mark [1 ]
机构
[1] Univ Sheffield, Sheffield, S Yorkshire, England
来源
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 10期
关键词
D O I
10.1002/art.23863
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine whether osteolysis after total hip arthroplasty (THA) is associated with common polymorphisms within the genes encoding the interieukin-1 (IL-1) family and IL-6, and to determine whether polymorphisms that are associated with osteolysis affect in vitro messenger RNA (mRNA) expression in human peripheral blood mononuclear cells (PBMCs) in response to wear particles. Methods. Unrelated white subjects of North European descent (n = 612) were recruited a mean of IT years after cemented THA for primary osteoarthritis. Of these subjects, 272 had previous osteolysis and 340 had no radiographic evidence of osteolysis (control group). Genomic DNA was genotyped for the following single-nucleotide polymorphisms (SNPs): IL1A +4845, IL1B +3954, IL1B -3737, IL1B -511, IL1RA +2018, IL6 -174, IL6 -572, and IL6 -597. In a subset of 60 subjects, PBMCs were extracted and stimulated with titanium particles and/or endotoxin, and cytokine mRNA expression was measured using quantitative real-time reverse transcriptase-polymerase chain reaction. Results. The odds ratio (OR) for osteolysis associated with carriage of the IL1RA +2018C allele was 0.66 (95% confidence interval [95% CI] 0.48-0.91) (P = 0.012). The remaining SNPs were not individually associated with osteolysis. The uncommon IL6 haplotype -174G/-572G/-597A (osteolysis group frequency 2.4%, control group frequency 0.8%) was associated with osteolysis (P = 0.02, calculated using Haploview software). The IL1RA +2018CC genotype was associated with increased mRNA expression compared with the +2018TT genotype in both unstimulated and stimulated PBMCs (P = 0.01 by analysis of variance, after Bonferroni correction). Conclusion. The IL1RA +2018C allele is associated with a decreased risk of osteolysis after THA and with increased IL-1 receptor antagonist mRNA expression in vitro. An uncommon haplotype within the promoter region of the gene for IL-6 is positively associated with osteolysis.
引用
收藏
页码:3157 / 3165
页数:9
相关论文
共 50 条
  • [21] Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis
    van der Paardt, M
    Crusius, JBA
    García-González, MA
    Baudoin, P
    Kostense, PJ
    Alizadeh, BZ
    Dijkmans, BAC
    Peña, AS
    van der Horst-Bruinsma, IE
    RHEUMATOLOGY, 2002, 41 (12) : 1419 - 1423
  • [22] Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in rheumatoid arthritis
    Huang, CM
    Tsai, FJ
    Wu, JY
    Wu, MC
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2001, 30 (04) : 225 - 228
  • [23] Inhibition of Interleukin-6 Signaling on Aortitis in Interleukin-1 Receptor Antagonist Deficient Mice
    Hada, Yoshiko
    Uchida, Haruhito A.
    Mukai, Tomoyuki
    Kojima, Fumiaki
    Otaka, Nozomu
    Onishi, Yasuhiro
    Morita, Yoshitaka
    Iwakura, Yoichiro
    Wada, Jun
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39
  • [24] Interleukin-6 and interleukin-1β polymorphisms in allergic contact eczema
    Westphal, GA
    Schnuch, A
    Neumann, C
    Hallier, E
    Reich, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R160 - R160
  • [25] Polymorphisms in interleukin-13 and interleukin-1 receptor antagonist genes and malaria in Ghanaian children
    Gyan, B
    Goka, B
    Cvetkovic, JT
    Perlmann, H
    Lefvert, AK
    Akanmori, B
    Troye-Blomberg, M
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 56 (06) : 619 - 622
  • [26] Interleukin-6 in the blood of patients with total hip arthroplasty without loosening
    Hernigou, P
    Intrator, L
    Bahrami, T
    Bensussan, A
    Farcet, JP
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1999, (366) : 147 - 154
  • [27] INTERLEUKIN-1 AND THE INTERLEUKIN-1 RECEPTOR ANTAGONIST
    DINARELLO, CA
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1991, 372 (04): : 239 - 239
  • [28] Interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    NUTRITION, 1995, 11 (05) : 492 - 494
  • [29] Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in Caucasian women
    Hefler, LA
    Grimm, C
    Lantzsch, T
    Lampe, D
    Leodolter, S
    Koelbl, H
    Heinze, G
    Reinthaller, A
    Tong-Cacsire, D
    Tempfer, C
    Zeillinger, R
    CLINICAL CANCER RESEARCH, 2005, 11 (16) : 5718 - 5721
  • [30] Interleukin-1β and interleukin-6 gene polymorphisms as risk factors for AD:: A prospective study
    Ravaglia, G
    Paola, F
    Maioli, F
    Martelli, M
    Montesi, F
    Bastagli, L
    Bianchin, M
    Chiappelli, M
    Tumini, E
    Bolondi, L
    Licastro, F
    EXPERIMENTAL GERONTOLOGY, 2006, 41 (01) : 85 - 92